Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Age of Transfused Blood in Critically Ill Adults Assessed

By LabMedica International staff writers
Posted on 06 Apr 2015
Blood for transfusion that has been stored for three weeks appears to be just as good as fresh blood for critically ill patients in need of red blood cell transfusion. More...


Current regulations permit the storage of red cells for up to 42 days, but prolonged storage has been associated with changes that may render red cells ineffective as oxygen carriers and that lead to the accumulation of substances that have untoward biologic effects.

An international team of scientists led by those at Sainte-Justine University Hospital (Montreal, QC, Canada) enrolled critically ill adults from tertiary care intensive care units (ICUs) at 64 centers; 26 in Canada, 20 in the United Kingdom, 10 in France, 7 in the Netherlands, and 1 in Belgium. Between March 2009 and May 2014, at the various centers, 1,211 patients were assigned to receive fresh red cells (fresh-blood group) and 1,219 patients were assigned to receive standard-issue red cells.

Red cells were stored a mean (± standard deviation) of 6.1 ± 4.9 days in the fresh-blood group as compared with 22.0 ± 8.4 days in the standard-blood group. At 90 days, 448 patients (37.0%) in the fresh-blood group and 430 patients (35.3%) in the standard-blood group had died. There were no significant between-group differences in any of the secondary outcomes such as major illnesses; duration of respiratory, hemodynamic, or renal support; length of stay in the hospital; and transfusion reactions or in the subgroup analyses.

The authors concluded that transfusion of fresh red cells, as compared with standard-issue red cells, did not decrease the 90-day mortality among critically ill adults. Blood transfusions save lives, but there is no need to worry about the safety of the age of blood routinely used in hospitals. Alan Tinmouth, MD, a physician and scientist and a coauthor of the study said, “Previous observational and laboratory studies have suggested that fresh blood may be better because of the breakdown of red blood cells and accumulation of toxins during storage. But this definitive clinical trial clearly shows that these changes do not affect the quality of blood.” The study was published on March 17, 2015, in the New England Journal of Medicine (NEJM).

Related Links:
Sainte-Justine University Hospital



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
HPV Molecular Test
BD Onclarity HPV Assay
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.